Pharmafile Logo
Pharmafocus logo
Advanced Search

Ferring Pharmaceuticals

Showing 3 posts of 3 posts found.

Ferring strengthens evidence for flexible dosing of follitropin delta in IVF

July 3, 2025
Research and Development Ferring Pharmaceuticals, IVF, Reproductive health, clinical trial, fertility treatment, in vitro fertilisation, ovarian hyperstimulation syndrome, pregnancy, reproductive health, reproductive medicine

Ferring Pharmaceuticals has reported that a conventional 15µg/day starting dose of follitropin delta (Rekovelle) provides comparable efficacy and safety to …

News

Ferring demonstrates effectiveness of a treat-to-target approach in mild-to-moderate ulcerative colitis in first major study

October 3, 2024
Research and Development Ferring Pharmaceuticals, Gastrointestinal tract, ulcerative colitis

1 October 2024 – Saint-Prex, Switzerland – Ferring Pharmaceuticals today announces results from the OPTIMISE study showing the first real-world …

News
Press release
baby-birth-born-161567

Ferring’s heat-stable drug could stop post-childbirth bleeding, WHO says

June 28, 2018
Research and Development Carbetocin, Ferring Pharmaceuticals, MSD, WHO, childbirth, pharma

A new formulation of a drug to prevent excessive bleeding in women after childbirth could save thousands of lives, says …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026